Dekristol D3 20 000 IU, 20 capsules — Made in Germany — Free Delivery

Product description

Soft capsules Dekristol 20,000 IU is prescribed for the following indications:

• Treatment of clinically proven vitamin D deficiency in adults.
• Prevention of vitamin D deficiency in high-risk patients.
• In addition to specific therapy for osteoporosis in patients with vitamin D deficiency or at high risk of vitamin D deficiency.

Structure

Active substance: cholecalciferol;

1 soft capsule contains colecalciferol (in the form of a concentrate 1.0 mIU / g (oily form)) 20.0 mg, which corresponds to 0.5 mg, or 20,000 IU, of vitamin D3;

Excipients: peanut oil, gelatin, glycerin 85%, medium chain triglycerides, purified water, alpha-tocopherol.

Contraindications

Hypersensitivity to the active substance, peanuts, soy or any other excipients contained in the drug.

Hypercalcemia.

Hypercalciuria.

Hypervitaminosis D.

Pseudohypoparathyroidism (the need for vitamin D may be lower than during the period of normal vitamin sensitivity, with the risk of prolonged overdose).

Nephrolithiasis (sechoamian disease).

Renal failure

Sarcoidosis

Tuberculosis.

Supplemental vitamin D intake (may lead to overdose).

Mode of application

For oral administration.

For adults, swallow the capsule whole with plenty of water, preferably with the main meal that day.

Application features

Pregnant

During pregnancy, Dekristol ® 20,000 IU can be prescribed only if there are clear indications and only used when it is absolutely necessary to eliminate vitamin D deficiency.

Children

Not recommended for use.

Drivers

Dekristol ® 20,000 MO does not affect or has little effect on the ability to drive a car or other mechanisms.

Overdose

Vitamin D3 regulates the metabolism of calcium and phosphates, after an overdose, hypercalcemia, hypercalciuria, renal calcidates and bone lesions occur, as well as changes in the cardiovascular system. Hypercalcemia occurs after the application of 50,000-100,000 IU of vitamin D3 per day.

Side effects

As a rule, adverse reactions are not observed when taken in the recommended doses.

In the case of individual sensitivity to the drug, it is rarely noted, or as a result of the use of very high doses for a long period, hypervitaminosis D may appear.

Interaction

The simultaneous use of anticonvulsants (for example, such as phenytoin and phenobarbital) or barbiturates (and possibly other drugs that induce liver enzymes) can lead to a decrease in the effect of vitamin D3 through metabolic inactivation.

Storage conditions

Store in its original packaging at a temperature not exceeding 25 ° C, protected from light. Keep out of the reach of children.

Shelf life is 3 years.